Eric Benevich

2021

In 2021, Eric Benevich earned a total compensation of $5.8M as Chief Commercial Officer at Neurocrine Biosciences, a 14% decrease compared to previous year.

Compensation breakdown

Bonus$213,960
Option Awards$2,625,019
Salary$534,900
Stock Awards$2,375,068
Other$56,139
Total$5,805,086

Benevich received $2.6M in option awards, accounting for 45% of the total pay in 2021.

Benevich also received $214K in bonus, $534.9K in salary, $2.4M in stock awards and $56.1K in other compensation.

Rankings

In 2021, Eric Benevich's compensation ranked 2,189th out of 12,405 executives tracked by ExecPay. In other words, Benevich earned more than 82.4% of executives.

ClassificationRankingPercentile
All
2,189
out of 12,405
82nd
Division
Manufacturing
851
out of 5,494
85th
Major group
Chemicals And Allied Products
326
out of 2,369
86th
Industry group
Drugs
282
out of 2,090
87th
Industry
Biological Products, Except Diagnostic Substances
88
out of 452
81st

Pay ratio

Eric Benevich's Pay$5,805,086
Median Employee's Pay$276,598
Pay Ratio

21

to 1

In 2021, the annual total compensation of Eric Benevich was $5,805,086.

The annual total compensation of the median employee at Neurocrine Biosciences was $276,598.

The ratio of Eric Benevich's pay to the pay of median employee was therefore 21 to one.

Source: SEC filing on April 7, 2022.

Benevich's colleagues

We found four more compensation records of executives who worked with Eric Benevich at Neurocrine Biosciences in 2021.

2021

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

2021

Jude Onyia

Neurocrine Biosciences

Chief Scientific Officer

2021

Eiry Roberts

Neurocrine Biosciences

Chief Medical Officer

2021

Matthew Abernethy

Neurocrine Biosciences

Chief Financial Officer

News

You may also like